TRPM7 and breast cancer: Moreover, targeted silencing of TRPM7 in MDA-MB-435 or MDA-MB-231 breast cancer cells through gene knockout resulted in enhanced contractility and increased focal adhesions, which were closely associated with diminished migratory and invasive capabilities (Middelbeek et al., 2012).